Clinical Trials

CytoAstra has partnered with the University of Arkansas for Medical Sciences (UAMS) in the development of the Cytophone using the In Vivo Photoacoustic Flow Cytometry (PAFC) diagnostic platform for multiple biomedical applications. Our collaborative findings suggest that the Cytophone is versatile and a highly sensitive technology that could fill the gap in early diagnosis and therapy for life-threatening diseases. These applications have been translated into the following clinical trials, beginning in 2016, focusing on melanoma, breast cancer, malaria, and strokes. These trials were conducted in collaboration with UAMS, University of Maryland, Yale University, Doctor’s Without Borders, and physicians in Cameroon.

Clinical Trials

In Vivo Real-time Detection of Circulating Melanoma Cells. United States. Ongoing.

In Vivo Detection of Circulating Clots in Patients with Thromboembolism. United States. Ongoing.

Malaria Trial in Africa. Pending.

Non-Invasive In Vivo Detection of Malaria Infected Red Blood Cells in Adults. Cameroon. Completed.

In Vivo Detecting Circulating Infected Red Blood Cells in Patients with Malaria. United States. Closed.

Multi-Functional Nanotubes for In Vivo Detection of Circulating Cancer Cells. United States. Completed.

A Systems Biology Approach to Malaria Immunity – Novel Diagnostic Method of Plasmodium Falciparum Detection Utilizing In Vivo Photoacoustic Flow Cytometry (PAFC). United States. Completed.